SciSparc Ltd. (NASDAQ:SPRC) Short Interest Update

SciSparc Ltd. (NASDAQ:SPRCGet Free Report) was the recipient of a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 795,500 shares, a growth of 411.9% from the December 15th total of 155,400 shares. Based on an average daily trading volume, of 7,930,000 shares, the days-to-cover ratio is currently 0.1 days. Currently, 7.7% of the company’s stock are sold short.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in SciSparc stock. Renaissance Technologies LLC purchased a new stake in shares of SciSparc Ltd. (NASDAQ:SPRCFree Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 39,700 shares of the company’s stock, valued at approximately $32,000. Renaissance Technologies LLC owned about 5.59% of SciSparc as of its most recent SEC filing. 25.06% of the stock is currently owned by institutional investors.

SciSparc Price Performance

NASDAQ SPRC traded up $0.04 during trading on Monday, hitting $0.85. 3,436,702 shares of the company traded hands, compared to its average volume of 32,369,609. SciSparc has a 12 month low of $0.20 and a 12 month high of $6.78. The business has a fifty day simple moving average of $0.34 and a 200 day simple moving average of $0.37.

About SciSparc

(Get Free Report)

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.

Featured Articles

Receive News & Ratings for SciSparc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SciSparc and related companies with MarketBeat.com's FREE daily email newsletter.